Sildenafil Tablet, Film Coated
Product Images NDC 68071-3832

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3832 3)

This text appears to contain information about a medication named SH 9222 Sildenafil 100mg produced by NuCare Pharmaceuticals Inc. The text includes details such as lot numbers, expiration dates, and serial numbers for the medication. It also provides a warning to keep the medication out of reach of children and store it at a controlled temperature between 68-77°F. Users are advised to consult their doctor for medical advice and report any side effects to FDA at 1-800-FDA-1088.*

FDA Label Image

Figure 1 (Sildenafil Fig1)

This text provides information on blood pressure measurements (in mmHg) before and after administering sildenafil (100mg) or placebo to healthy volunteers. It includes data on systolic blood pressure pre-dose and at various post-dose time points. The text indicates that the study is evaluating the change in sitting systolic blood pressure from baseline in healthy volunteers.*

FDA Label Image

Figure 2 (Sildenafil Fig2)

This text provides data on the change in systolic blood pressure (SBP) in mmHg over time after the administration of different medications. The figure displays the mean standing systolic blood pressure change from baseline at various time intervals postdose. One group was given Doxazosin + Placebo, while the other group received Doxazosin + Sildenafil 25 mg.*

FDA Label Image

Figure 3 (Sildenafil Fig3)

FDA Label Image

Figure 4 (Sildenafil Fig4)

The text provides information about the comparison of two treatments, one with Doxazosin and Sildenafil 100 mg and the other with Doxazosin and Placebo. It includes a figure showing the mean standing systolic blood pressure change from baseline over time after dosing.*

FDA Label Image

Figure 5 (Sildenafil Fig5)

This is a graph illustrating the mean Sildenafil plasma concentrations in healthy male volunteers over time post dose in hours using a commercial tablet. The data is displayed for up to 24 hours post-dose showing the levels at various time points.*

FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

This is not-available.*

FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

FDA Label Image

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.